China's 12th national centralized drug procurement will open bids in Shanghai on
July 31; bidders begin submitting price materials from 07:30. The tender
includes 65 drugs spanning anti-infectives, oncology, antithrombotics,
antidiabetics, antihypertensives, lipid-lowering, rheumatology/autoimmune and
analgesic/anti-inflammatory categories. At the bid opening, banks and insurers
including Bank of China, Sinosure, China Merchants Bank, SPD Bank, Shanghai Bank
and the China Drug Price Registration System introduced financing and support
products for bidders, such as "procurement loans", "traceability-code loans" and
drug price registration services.
